Concomitant acute myocardial infarction and stress cardiomyopathy

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
César Jiménez-Méndez ◽  
Alberto Cecconi ◽  
Alberto Vera ◽  
María José Olivera ◽  
Luis Jesús Jiménez-Borreguero ◽  
...  
2013 ◽  
Vol 61 (10) ◽  
pp. E127 ◽  
Author(s):  
Timothy P. Fitzgibbons ◽  
Jeanine Ward ◽  
Gerard P. Aurigemma ◽  
Kahraman Tanriverdi ◽  
Jane E. Freedman ◽  
...  

PLoS ONE ◽  
2013 ◽  
Vol 8 (7) ◽  
pp. e68504 ◽  
Author(s):  
Christina Chan ◽  
John Elliott ◽  
Richard Troughton ◽  
Christopher Frampton ◽  
David Smyth ◽  
...  

Author(s):  
JSY Ho ◽  
CH Sia ◽  
JN Ngiam ◽  
PH Loh ◽  
NWS Chew ◽  
...  

In Singapore, 9.03 million doses of the mRNA COVID-19 vaccines by Pfizer-BioNTech and Moderna have been administered, and 4.46 million people are fully vaccinated. An additional 87,000 people have been vaccinated with vaccines in World Health Organization’s Emergency Use Listing. The aim of this review is to explore the reported cardiac adverse events associated with different types of COVID-19 vaccines. 42 studies that reported cardiac side effects after COVID-19 vaccination were included in this study. Reported COVID-19 vaccine-associated cardiac adverse events were mainly myocarditis and pericarditis, most commonly seen in adolescent and young adult male individuals after mRNA vaccination. Reports of other events such as acute myocardial infarction, arrhythmia and stress cardiomyopathy were rare. Outcomes of post-vaccine myocarditis and pericarditis were good. Given the good vaccine efficacy and the high number of cases of infection, hospitalisation and death that could potentially be prevented, COVID-19 vaccine remains of overall benefit, based on the current available data.


2020 ◽  
Vol 132 ◽  
pp. 29-35
Author(s):  
Saraschandra Vallabhajosyula ◽  
Gregory W. Barsness ◽  
Joerg Herrmann ◽  
Nandan S. Anavekar ◽  
Rajiv Gulati ◽  
...  

2018 ◽  
Vol 131 (2) ◽  
pp. 202-205 ◽  
Author(s):  
Iliana S. Hurtado Rendón ◽  
Diego Alcivar ◽  
Juan Pablo Rodriguez-Escudero ◽  
Kevin Silver

Author(s):  
Masahiro Ono ◽  
Kaoru Aihara ◽  
Gompachi Yajima

The pathogenesis of the arteriosclerosis in the acute myocardial infarction is the matter of the extensive survey with the transmission electron microscopy in experimental and clinical materials. In the previous communication,the authors have clarified that the two types of the coronary vascular changes could exist. The first category is the case in which we had failed to observe no occlusive changes of the coronary vessels which eventually form the myocardial infarction. The next category is the case in which occlusive -thrombotic changes are observed in which the myocardial infarction will be taken placed as the final event. The authors incline to designate the former category as the non-occlusive-non thrombotic lesions. The most important findings in both cases are the “mechanical destruction of the vascular wall and imbibition of the serous component” which are most frequently observed at the proximal portion of the coronary main trunk.


Sign in / Sign up

Export Citation Format

Share Document